Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Molecular Cancer Therapeutics|November 21, 2019
Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin TreatmentXimena Rosas-Plaza, Gerda de Vries, Gert Jan Meersma, et al.
The Lancet. Oncology|August 2, 2005
Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balanceBrigitte M T Hougardy, John H Maduro, Ate G J van der Zee, et al.
Medicinal Research Reviews|March 13, 2018
Avenues to molecular imaging of dying cells: Focus on cancerAnna A Rybczynska, Hendrikus H Boersma, Steven de Jong, et al.
Oncotarget|September 8, 2016
Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumabMartin Pool, Arjan Kol, Marjolijn N Lub-de Hooge, et al.
The Journal of Pathology|September 29, 2011
MiR-17/106b seed family regulates p21 in Hodgkin's lymphomaJohan H Gibcus, Bart-Jan Kroesen, Roelof Koster, et al.
Gynecologic Oncology|May 3, 2005
Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and BidBrigitte M T Hougardy, Ate G J van der Zee, Fiona A J van den Heuvel, et al.
Genome Medicine|October 22, 2016
Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathwaysTushar Tomar, Steven de Jong, Nicolette G Alkema, et al.
Cell Cycle (Georgetown, Tex.)|November 21, 2012
Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependentAlessandra di Pietro, Roelof Koster, Wytske Boersma-van Eck, et al.
Scientific Reports|October 7, 2015
Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methodsNicolette G Alkema, Tushar Tomar, Evelien W Duiker, et al.
The Journal of Clinical Investigation|September 3, 2010
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancerRoelof Koster, Alessandra di Pietro, Hetty Timmer-Bosscha, et al.
Pageof 14